641 related articles for article (PubMed ID: 28877748)
1. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Khan A; Benthin C; Zeno B; Albertson TE; Boyd J; Christie JD; Hall R; Poirier G; Ronco JJ; Tidswell M; Hardes K; Powley WM; Wright TJ; Siederer SK; Fairman DA; Lipson DA; Bayliffe AI; Lazaar AL
Crit Care; 2017 Sep; 21(1):234. PubMed ID: 28877748
[TBL] [Abstract][Full Text] [Related]
2. Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study.
Hall DA; Hanrott K; Badorrek P; Berliner D; Budd DC; Eames R; Powley WM; Hewens D; Siederer S; Lazaar AL; Cahn A; Hohlfeld JM
Pulm Ther; 2021 Dec; 7(2):487-501. PubMed ID: 34189703
[TBL] [Abstract][Full Text] [Related]
3. Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets.
Treml B; Neu N; Kleinsasser A; Gritsch C; Finsterwalder T; Geiger R; Schuster M; Janzek E; Loibner H; Penninger J; Loeckinger A
Crit Care Med; 2010 Feb; 38(2):596-601. PubMed ID: 19851091
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.
Vincent JL; Artigas A; Petersen LC; Meyer C
Crit Care Med; 2009 Jun; 37(6):1874-80. PubMed ID: 19384216
[TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial.
Tongyoo S; Permpikul C; Mongkolpun W; Vattanavanit V; Udompanturak S; Kocak M; Meduri GU
Crit Care; 2016 Oct; 20(1):329. PubMed ID: 27741949
[TBL] [Abstract][Full Text] [Related]
6. An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension.
Simon MA; Hanrott K; Budd DC; Torres F; Grünig E; Escribano-Subias P; Meseguer ML; Halank M; Opitz C; Hall DA; Hewens D; Powley WM; Siederer S; Bayliffe A; Lazaar AL; Cahn A; Rosenkranz S
Pulm Circ; 2022 Jan; 12(1):e12024. PubMed ID: 35506108
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.
Haschke M; Schuster M; Poglitsch M; Loibner H; Salzberg M; Bruggisser M; Penninger J; Krähenbühl S
Clin Pharmacokinet; 2013 Sep; 52(9):783-92. PubMed ID: 23681967
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome.
Drago BB; Kimura D; Rovnaghi CR; Schwingshackl A; Rayburn M; Meduri GU; Anand KJ
Pediatr Crit Care Med; 2015 Mar; 16(3):e74-81. PubMed ID: 25634565
[TBL] [Abstract][Full Text] [Related]
9. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.
Hemnes AR; Rathinasabapathy A; Austin EA; Brittain EL; Carrier EJ; Chen X; Fessel JP; Fike CD; Fong P; Fortune N; Gerszten RE; Johnson JA; Kaplowitz M; Newman JH; Piana R; Pugh ME; Rice TW; Robbins IM; Wheeler L; Yu C; Loyd JE; West J
Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29903860
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.
Bellingan G; Brealey D; Mancebo J; Mercat A; Patroniti N; Pettilä V; Quintel M; Vincent JL; Maksimow M; Jalkanen M; Piippo I; Ranieri VM
Trials; 2017 Nov; 18(1):536. PubMed ID: 29132404
[TBL] [Abstract][Full Text] [Related]
11. Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study.
Reddy R; Asante I; Liu S; Parikh P; Liebler J; Borok Z; Rodgers K; Baydur A; Louie SG
PLoS One; 2019; 14(3):e0213096. PubMed ID: 30845246
[TBL] [Abstract][Full Text] [Related]
12. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.
Wösten-van Asperen RM; Lutter R; Specht PA; Moll GN; van Woensel JB; van der Loos CM; van Goor H; Kamilic J; Florquin S; Bos AP
J Pathol; 2011 Dec; 225(4):618-27. PubMed ID: 22009550
[TBL] [Abstract][Full Text] [Related]
13. Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.
Krenn K; Lucas R; Croizé A; Boehme S; Klein KU; Hermann R; Markstaller K; Ullrich R
Crit Care; 2017 Jul; 21(1):194. PubMed ID: 28750677
[TBL] [Abstract][Full Text] [Related]
14. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure.
Thomas NJ; Guardia CG; Moya FR; Cheifetz IM; Markovitz B; Cruces P; Barton P; Segal R; Simmons P; Randolph AG;
Pediatr Crit Care Med; 2012 Nov; 13(6):646-53. PubMed ID: 22791092
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome.
Jerng JS; Yu CJ; Wang HC; Chen KY; Cheng SL; Yang PC
Crit Care Med; 2006 Apr; 34(4):1001-6. PubMed ID: 16484896
[TBL] [Abstract][Full Text] [Related]
16. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
17. High-dose Oral Ambroxol for Early Treatment of Pulmonary Acute Respiratory Distress Syndrome: an Exploratory, Randomized, Controlled Pilot Trial.
Baranwal AK; Murthy AS; Singhi SC
J Trop Pediatr; 2015 Oct; 61(5):339-50. PubMed ID: 26130623
[TBL] [Abstract][Full Text] [Related]
18. [Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome].
Li HB; Zi PP; Shi HJ; Gao M; Sun RQ
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(41):3354-3359. PubMed ID: 30440128
[No Abstract] [Full Text] [Related]
19. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
Bellingan G; Maksimow M; Howell DC; Stotz M; Beale R; Beatty M; Walsh T; Binning A; Davidson A; Kuper M; Shah S; Cooper J; Waris M; Yegutkin GG; Jalkanen J; Salmi M; Piippo I; Jalkanen M; Montgomery H; Jalkanen S
Lancet Respir Med; 2014 Feb; 2(2):98-107. PubMed ID: 24503265
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Imai Y; Kuba K; Penninger JM
Cell Mol Life Sci; 2007 Aug; 64(15):2006-12. PubMed ID: 17558469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
